Early Percutaneous Transluminal Angioplasty in Diabetic Foot Syndrome (PTA-DFS)

Condition(s) studied

Investigational drug(s) / intervention(s)

Percutaneous transluminal angioplasty: Percutaneous transluminal angioplasty of the leg

Study summary

The planned study is a Randomized Controlled Monocentric Trial, which will provide evidence on whether early angiography in percutaneous transluminal angioplasty (PTA) readiness ("immediate" treatment, within 48h) has advantages over the "standard of care", i.e., an elective procedure ("elective PTA") for the treatment of diabetic foot ulcer (DFU). The primary study endpoint is to investigate the impact of the "early PTA" within 48 hours on wound-healing assessed by wound area changes after PTA using a 3D-camera with artificial intelligence (AI)-based wound-analysis-system. The secondary endpoint is the effect of early PTA on the combined occurrence of major adverse limb (MALE) and cardiac events (MACE) over 12 months post-angioplasty using time-to-event analysis. Data will be collected at baseline, 24 hours, 1, 2, 3, 6, and 12 months after PTA. Diabetic kidney disease, distal symmetric polyneuropathy, retinopathy, cardiomyopathy, laboratory analyses, clinical scores, AI-based fundus photography, echocardiography, duplex sonography, and pulse oscillography will be assessed. Explanatory variables for wound healing are wound microbiome changes using whole-genome sequencing and oxygen saturation of the wound environment measured using near-infrared spectroscopy. Altered microbiome composition in ulcers can lead to severe local and systemic infections and complications, including major amputations. Nevertheless, the specific significance of the wound microbiome composition in chronic ischaemic ulcers in type 2 diabetes and the impact of PTA on the wound microbiome in type 2 diabetes is unclear. The exact timing for treating peripheral arterial disease (PAD) by revascularization in DFU after initial diagnosis is unknown and has yet to be fully understood.

Eligibility

Primary outcome measure(s)

• Effect of PTA within 48h on changes of the wound area — Wound area difference from baseline to last visit
  Assessment of the impact of 'early' PTA (performed within 48 hours) on wound healing, evaluated through changes in wound area using a 3D camera with an AI-based wound analysis system over a 12-month follow-up period.

Trial sites (1)

More Heinrich-Heine University, Duesseldorf trials in Germany

Other trials for the same condition